Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: A retrospective, open label, uncontrolled study in a VA hospital

Current Medical Research and Opinion

Volumn 20, Issue 5, 2004, Pages 577-580

  Hasegawa, Hisanori ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anticonvulsant; Neuralgia; Neuropathic pain; Partial seizures; Refractory epilepsy; Zonisamide

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZONISAMIDE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; DISEASE CONTROL; DIZZINESS; DRUG APPROVAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; DRUG UTILIZATION; EPILEPSY; FOCAL EPILEPSY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; NAUSEA; NEPHROLITHIASIS; NEUROPATHIC PAIN; OPEN STUDY; OUTCOMES RESEARCH; PAIN ASSESSMENT; PUBLIC HOSPITAL; RASH; RETROSPECTIVE STUDY; SOMNOLENCE; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHRONIC DISEASE; EPILEPSY; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; PAIN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 2542439540     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125003313     Document Type: Article

References (15)

1. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Stat 1999;10(200):82
2. Benbadis SR, Agrawal VK. Partial epilepsies. Available at: http://www.edmedicine.com/neuro/topic623.htm. Accessed April 26, 2003
3. Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy (Cochrane Review) In: The Cochrane Library, Issue 1, 2003. Oxford: Update Software. Date of most recent amendment: 3 January 2002
4. Zonegran [package insert]. San Diego, CA: Elan Pharmaceuticals Inc; 2000
5. Masuda Y, Ishizaki M, Shimizu M. Zonisamide: pharmacology and clinical efficacy in epilepsy. CNS Drug Review 1996;4:341-60
6. Leppik IE. Zonisamide. Epilepsia 1999;40(Suppl 5):S23-S29
7. Faught E, Ayala R, Montouris GG, Leppik IE, Zonisamide 922 Trial Group. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774-9
8. Leppik IE, Willmore LJ, Homan RW, et al. Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res 1993;14:165-73
9. Backonja MM. Use of anticonvulsants for the treatment of neuropathic pain. Neurology 2002;59(Suppl 2):S14-S17
10. Seino M, Ohkuma T, et al. Efficacy evaluation of AD-810 (zonisamide): double-blind study comparing with carbamazepine. J Clin Exp Med 1988;144:257-91
11. Fukushima K, Yagi K, Seino M, et al. [Phase II clinical trial of a new antiepileptic drug, zonisamide (ZNA) in pediatric epilepsy patients]. Shonika-Rinsho 1987;40:3389-97 [in Japanese]
12. Hasegawa S, Ito N, Kaji S, et al. [Clinical evaluation of AD-810 (zonisamide) to partial seizure disorder]. Rinsho-Iyaku 1988;4:189-99 [in Japanese]
13. Schmidt D, Jacob R, Loiseau P, et al. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 1993;15:67-73
14. Wong IC, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Safety 2002;23:35-56
15. Kayano Y, Mizutsu N, Kinoshita T, et al. [Novel anticonvulsant zonisamide: clinical outcome for treatment of seizure]. Igaku-to-Yakugaku 1987;18:1641-9 [in Japanese]